Review
Complement defects: apoptotic cell and immune complexes clearance deficiency
Complement deficiency | Locus | Inheritance pattern | Clinical manifestations | Infection susceptibility |
---|---|---|---|---|
C1q | 1p36.3-p34.1 | AR | Nephritis, CNS involvement, photosensitivity | Encapsulated bacteria |
C1r/C1s | 12p13 | AR | Nephritis | Encapsulated bacteria |
C4 | 6p21.3 | AR | Multiorgan involvement; glomerulonephritis | Encapsulated bacteria |
C2 | 6p21.3 | AR | Photosensitivity and articular involvement; mild or absent renal, neurological or pleuropericardial involvement | Pyogenic infections; encapsulated bacteria; Streptococcus pneumoniae sepsis and meningitis |
C3 | 19q13 | AR | Malar rash, photosensitivity, arthralgia and Raynaud’s phenomenon | Recurrent pyogenic infections |
C5-C9: MAC | C5/9p34.1, C6-C7/5p13, C8A-C8B/1p32, C8G/9, C9/5p13 | AR | Multiorgan involvement | Neisserial infections |
Apoptosis defects
Interferon (IFN)-α hyperproduction
Gene mutated/protein | Chromosome | Inheritance | Clinical features |
---|---|---|---|
TREX1/TREX1 | 3p21 | AD | Chilblain lupus, intracerebral calcifications |
DNAse I/ DNase I | 16p13 | AD | Systemic lupus, Sjögren syndrome,high levels of antinucleosomal antibodies |
DNAse IL3/ DNase1L3 | 3p14 | AR | Early-onset SLE, antinuclear antibodies, anti-dsDNA, ANCA |
AGS5/SAMHD1 | 20q11 | AD | Chilblain lupus, intracerebral calcifications, mental retardation |
ACP5/TRAP | 19p13 | AR | Growth retardation, spondyloenchondrodysplasia, SLE, Sjögren, vitiligo, myositis, Raynaud, ANA, anti-dsDNA |